Company news
Sensei Biotherapeutics, Inc. news in 2026
Sensei Biotherapeutics, Inc.'s news releases, calls and decks from 2026, newest first.
Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer
June 15, 2026
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
June 5, 2026
Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 15, 2026
Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer
May 5, 2026
Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
April 9, 2026
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update
March 29, 2026
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 24, 2026
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement
February 18, 2026
Egle Therapeutics Appoints John Celebi as Chief Executive Officer
January 7, 2026
Decks in 2026
- Faeth Therapeutics — Corporate Update (November 2026)
Corporate update · 36 slides · Nov 9, 2026
- Faeth Therapeutics — Investor Day (October 2026)
Investor day · 84 slides · Oct 6, 2026
- Faeth Therapeutics — Investor Presentation (October 2026)
Investor deck · 39 slides · October 2026
- Merger or Acquisition (February 2026)
Merger or acquisition · 34 slides · Feb 18, 2026